Rubicon Research Reports Strong Q1 FY27 Earnings, Shares Reach New High
Rubicon Research reported strong Q1 FY27 financial results, with net profit rising 95.8% year-on-year to Rs 84.78 crore and net sales increasing 51.6% to Rs 534.34 crore. EBITDA grew 64.6% YoY to Rs 131.2 crore, with improved margins supported by specialty products and stable pricing. The company's share price surged over 9%, reaching a new high amid increased trading volumes. Revenue growth was broad-based, and USD revenue rose 32% YoY, reflecting the company's expanding presence in the US generic pharmaceutical market.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 39/100.
Outlets measured: businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 17 Aug, 09:42 am. Other outlets followed.
- 1